Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Odyssey Therapeutics, Inc. (ODTX) had Return on Equity of 7.31% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-38.26M |
|
-- |
|
-- |
|
39.78M |
|
-39.78M |
|
1.58M |
|
-38.20M |
|
-38.20M |
|
-38.26M |
|
-38.26M |
|
-38.26M |
|
-38.26M |
|
-39.78M |
|
-38.61M |
|
5.66M |
|
5.66M |
|
-6.77 |
|
-6.77 |
|
| Balance Sheet Financials | |
185.10M |
|
6.56M |
|
43.97M |
|
229.07M |
|
22.21M |
|
-- |
|
27.00M |
|
49.21M |
|
-523.69M |
|
165.63M |
|
179.86M |
|
2.48M |
|
| Cash Flow Statement Financials | |
-41.03M |
|
34.80M |
|
0.48M |
|
44.90M |
|
39.17M |
|
-5.72M |
|
2.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
7.31% |
-23.10% |
|
-16.70% |
|
-21.27% |
|
72.50 |
|
-7.28 |
|
-7.26 |
|